These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2401172)

  • 21. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
    Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
    Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 1: Positive predictive value of occult blood testing].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(19):1007-9. PubMed ID: 3439213
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a fecal occult blood test with reverse passive hemagglutination for colorectal neoplasm screening.
    Zhou L; Yu H; Zheng S
    World J Gastroenterol; 1997 Mar; 3(1):38-40. PubMed ID: 27006583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening for colorectal cancer based on our experience with early colorectal cancer and adenoma].
    Miyazaki I; Takashima S; Takigawa Y; Kosaka T; Ueno K
    Gan No Rinsho; 1985 Jan; 31(1):52-6. PubMed ID: 3981802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate colorectal cancer screening: findings and implications.
    Fisher DA; Judd L; Sanford NS
    Am J Gastroenterol; 2005 Nov; 100(11):2526-30. PubMed ID: 16279910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Randomized controlled trial of sequence mass screening program for colorectal cancer].
    Liu X; Zheng S; Chen K; Ma X; Zhou L; Yu H; Yao K; Chen K; Cai S; Zhang S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Dec; 21(6):430-3. PubMed ID: 11860828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
    Sharma VK; Corder FA; Fancher J; Howden CW
    Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone.
    Tárraga P; García-Olmo D; Celada A; García-Molinero Mf; Divison JA; Casado C
    Rev Esp Enferm Dig; 1999 May; 91(5):335-44. PubMed ID: 10362875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mass screening for colorectal cancer--issues and future prospects].
    Kobayashi S
    Gan No Rinsho; 1984 May; 30(6 Suppl):611-5. PubMed ID: 6748232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.
    Wahrendorf J; Robra BP; Wiebelt H; Oberhausen R; Weiland M; Dhom G
    Eur J Cancer Prev; 1993 May; 2(3):221-7. PubMed ID: 8490540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer screening in average risk individuals.
    Huang CS; Lal SK; Farraye FA
    Cancer Causes Control; 2005 Mar; 16(2):171-88. PubMed ID: 15868457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening for colorectal cancer with fecal occult blood--an offer to the population?].
    Kronborg O
    Ugeskr Laeger; 1997 Aug; 159(33):4991-2. PubMed ID: 9281216
    [No Abstract]   [Full Text] [Related]  

  • 36. [The status of colon cancer screening].
    Fujiyoshi T
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2223-31. PubMed ID: 1929442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of fecal occult blood screening in automated multiphasic health testing and services.
    Nishikawa A; Okuda T; Kubota I; Azuma H; Tanaka T; Koyasu T; Kumazaki N; Iwata H; Tanaka T; Kato K
    Jpn J Clin Oncol; 1987 Jun; 17(2):107-12. PubMed ID: 3613137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Screening for cancer of the large intestine].
    Gnauck R
    Wien Med Wochenschr; 1988 Jun; 138(11-12):257-60. PubMed ID: 3051684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
    Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for colorectal cancer: the rationale and a recent advance in the detection of fecal occult blood.
    Friend WG
    Prog Clin Biol Res; 1985; 186():65-76. PubMed ID: 4034607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.